(Q37082037)

18 August 2017

The frequency and outcome of lupus nephritis: results from an international inception cohort study (English)

1 reference

18 August 2017

1 reference

Ronald van Vollenhoven

30

Ronald F van Vollenhoven

0 references

Guillermo Ruiz-Irastorza

Guillermo Ruiz-Irastorza

33

0 references

Sang-Cheol Bae

Sang-Cheol Bae

7

0 references

Caroline Gordon

Caroline Gordon

6

0 references

Dafna D. Gladman

16

Dafna D Gladman

1 reference

18 August 2017

12

David A Isenberg

1 reference

18 August 2017

29

Munther A Khamashta

1 reference

18 August 2017

18

Michelle Petri

1 reference

18 August 2017

32

Manuel Ramos-Casals

1 reference

18 August 2017

23

Graciela S Alarcón

1 reference

18 August 2017

11

Joan T Merrill

1 reference

18 August 2017

38

Diane L Kamen

1 reference

18 August 2017

22

Cynthia Aranow

1 reference

18 August 2017

28

Susan Manzi

1 reference

18 August 2017

8

Sasha Bernatsky

1 reference

18 August 2017

Rosalind Ramsey-Goldman

21

Rosalind Ramsey-Goldman

1 reference

18 August 2017

37

Kenneth C Kalunian

1 reference

18 August 2017

14

Ellen M Ginzler

1 reference

18 August 2017

20

Mary Anne Dooley

1 reference

18 August 2017

40

Christine A Peschken

1 reference

18 August 2017

4

Murray B Urowitz

1 reference

18 August 2017

15

Paul Fortin

1 reference

18 August 2017

9

Ann E Clarke

1 reference

18 August 2017

1

John G Hanly

1 reference

18 August 2017

2

Aidan G O'Keeffe

1 reference

18 August 2017

Jorge Sánchez-Guerrero

17

Jorge Sanchez-Guerrero

1 reference

18 August 2017

5

Juanita Romero-Diaz

1 reference

18 August 2017

26

Ola Nived

1 reference

18 August 2017

41

Soren Jacobsen

1 reference

18 August 2017

42

Anca Askanase

1 reference

18 August 2017

27

Gunnar K Sturfelt

1 reference

18 August 2017

25

Kristjan Steinsson

1 reference

18 August 2017

24

Barri J Fessler

1 reference

18 August 2017

31

Asad A Zoma

1 reference

18 August 2017

34

S Sam Lim

1 reference

18 August 2017

43

Chris Theriault

1 reference

18 August 2017

44

Kara Thompson

1 reference

18 August 2017

45

Vernon Farewell

1 reference

18 August 2017

35

Thomas Stoll

1 reference

18 August 2017

Li Su

3

1 reference

18 August 2017

Daniel J Wallace

10

1 reference

18 August 2017

Anisur Rahman

13

1 reference

18 August 2017

Ian N Bruce

19

1 reference

18 August 2017

Murat Inanc

36

1 reference

18 August 2017

Peter Maddison

39

1 reference

18 August 2017

5 September 2015

1 reference

18 August 2017

1 reference

18 August 2017

55

1 reference

18 August 2017

2

1 reference

18 August 2017

252-262

1 reference

Population-based incidence and prevalence of systemic lupus erythematosus: the Michigan Lupus Epidemiology and Surveillance program

18 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4939728

The incidence and prevalence of systemic lupus erythematosus, 2002-2004: The Georgia Lupus Registry

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4939728

Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4939728

American College of Rheumatology guidelines for screening, treatment, and management of lupus nephritis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4939728

Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: the Lupus Nephritis Assessment with Rituximab study

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4939728

Trends in the incidence, demographics, and outcomes of end-stage renal disease due to lupus nephritis in the US from 1995 to 2006.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4939728

Clinical improvements in proliferative vs membranous lupus nephritis following B-cell depletion: pooled data from two cohorts

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4939728

Mycophenolate mofetil versus cyclophosphamide for induction treatment of lupus nephritis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4939728

The 10-year follow-up data of the Euro-Lupus Nephritis Trial comparing low-dose and high-dose intravenous cyclophosphamide

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4939728

Changing patterns in mortality and disease outcomes for patients with systemic lupus erythematosus

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4939728

Time to renal disease and end-stage renal disease in PROFILE: a multiethnic lupus cohort

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4939728

Mortality in systemic lupus erythematosus

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4939728

The classification of glomerulonephritis in systemic lupus erythematosus revisited

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4939728

Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1,000 patients

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4939728

Differences by race, sex and age in the clinical and immunologic features of recently diagnosed systemic lupus erythematosus patients in the southeastern United States.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4939728

K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4939728

Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4939728

The significance of arterial hypertension at the onset of clinical lupus nephritis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4939728

The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4939728

The 1982 revised criteria for the classification of systemic lupus erythematosus

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4939728

Safety and efficacy of rituximab in systemic lupus erythematosus: results from 136 patients from the French AutoImmunity and Rituximab registry

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4939728

Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE.

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4939728

Clinical prognostic factors in lupus nephritis. The importance of hypertension and smoking

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4939728

Correlation of 24-hour urinary protein quantification with spot urine protein:creatinine ratio in lupus nephritis.

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4939728

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4939728

Assessment of a lupus nephritis cohort over a 30-year period.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4939728

The prognosis of severe lupus nephritis based on the Modification of Diet in Renal Disease (MDRD) study estimated glomerular filtration rate.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4939728

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4939728

Systemic Lupus International Collaborating Group--onwards and upwards?

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4939728

An assessment of renal failure in an SLE cohort with special reference to ethnicity, over a 25-year period

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4939728

Mycophenolate mofetil or intravenous cyclophosphamide for lupus nephritis

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4939728

Long-term study of mycophenolate mofetil as continuous induction and maintenance treatment for diffuse proliferative lupus nephritis

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4939728

Urine protein-to-creatinine ratio is a reliable measure of proteinuria in lupus nephritis.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4939728

Immunosuppressive therapy in lupus nephritis: the Euro-Lupus Nephritis Trial, a randomized trial of low-dose versus high-dose intravenous cyclophosphamide

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4939728

A multicentre study of 513 Danish patients with systemic lupus erythematosus. I. Disease manifestations and analyses of clinical subsets.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4939728

Disease activity, cumulative damage and quality of life in systematic lupus erythematosus: results of a cross-sectional study

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4939728

Systemic lupus erythematosus: clinical and immunologic patterns of disease expression in a cohort of 1,000 patients. The European Working Party on Systemic Lupus Erythematosus.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4939728

Mycophenolate versus Azathioprine as Maintenance Therapy for Lupus Nephritis

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4939728

Goodpasture syndrome during the course of a Schönlein-Henoch purpura.

3 September 2018

1 reference

Crossref

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEV311

Long-term efficacy of azathioprine treatment for proliferative lupus nephritis

21 January 2018

1 reference

12 December 2020

Determination of prognosis in chronic disease, illustrated by systemic lupus erythematosus

1 reference

12 December 2020

Quality of life comparison between corticosteroid- and-mycofenolate mofetil and corticosteroid- and-oral cyclophosphamide in the treatment of severe lupus nephritis

1 reference

12 December 2020

Diffuse proliferative lupus nephritis: identification of specific pathologic features affecting renal outcome

1 reference

12 December 2020

Baseline characteristics of a multiethnic lupus cohort: PROFILE

1 reference

12 December 2020

Persistent proteinuria and dyslipidemia increase the risk of progressive chronic kidney disease in lupus erythematosus

1 reference

12 December 2020

Efficacy of mycophenolate mofetil in patients with diffuse proliferative lupus nephritis. Hong Kong-Guangzhou Nephrology Study Group

1 reference

12 December 2020

10.1093/RHEUMATOLOGY/KEV311

Identifiers

DOI

1 reference

18 August 2017

1 reference

18 August 2017

PubMed publication ID

26342222

1 reference